In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Auris Medical Holding AG. Trade Record

NASDAQ:EARS Auris Medical Holding AG stock gains 12.45% Exit Mar 27, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart EARS Mar 10, 2017, priceSeries
About Auris Medical Holding AG

Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its product candidates include AM-101, which is in phase III clinical development for the treatment of acute inner ear tinnitus; and AM-111 that is in phase III clinical development for the treatment of acute inner ear hearing loss. The company is also developing AM-125 for the treatment of vestibular disorders; and other pre-clinical stage products comprising AM-102 and AM-123. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, as well as drug delivery devices and formulations for local administration of therapeutic substances to the inner ear for the treatment of ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.

Trade Information
Trade Type
LONG
ReliabilityScore™
90.00
Entry Date
Mar 10, 2017
Entry Price
156.00
Sell Date
Mar 27, 2017
Sell Price
175.42
Net Gain
12.45%
Hold Time
11 Trading Days